SlidesetTokyo Hepatitis Clinical Forum 2019Immunological Aspects of HBV and HCV Infection - Tatsuya Kanto, MD, PhDView Slideset
SlidesetTokyo Hepatitis Clinical Forum 2019New Anti-HBV Drugs in the Pipeline - Man-Fung Yuen, DSc, MD, PhDView Slideset
SlidesetTokyo Hepatitis Clinical Forum 2019Management of Hepatitis B Reactivation - Yasuhito Tanaka, MD, PhDView Slideset
SlidesetTokyo Hepatitis Clinical Forum 2019Challenges in the Era of Hepatitis C Cure - Naoya Sakamoto, MDView Slideset
MNMark NelsonMD, MBBS, FRCPSlidesetTokyo Hepatitis Clinical Forum 2019Hepatitis C Management in Special Populations - Mark Nelson, MDView Slideset
SlidesetTokyo Hepatitis Clinical Forum 2019Trend of NAFLD/ NASH in Japan - Katsutoshi Tokushige, MDView Slideset
VideoTokyo Hepatitis Clinical Forum 2019Immunological Aspects of HBV and HCV Infection - Tatsuya Kanto, MD, PhDView Video
VideoTokyo Hepatitis Clinical Forum 2019Evolving Treatment Paradigm and Future Landscape in HCC - Masafumi Ikeda, MDView Video
VideoTokyo Hepatitis Clinical Forum 2019Current and Future Local Therapies for Early Stage HCC - Shi-Ming Lin, MDView Video
VideoTokyo Hepatitis Clinical Forum 2019Progress in Hepatitis B Cure Research - Peter Revill, MD, PhDView Video
MHMargaret HellardAM, MBBS, FRACP, FAFPHM, PhDVideoTokyo Hepatitis Clinical Forum 2019Update on Hepatitis C Elimination Strategies - Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhDView Video
